Free Trial

Editas Medicine (EDIT) News Today

Editas Medicine logo
$3.08 -0.04 (-1.13%)
As of 02:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EDIT Latest News

Editas Medicine (NASDAQ:EDIT) Stock Rating Lowered by Wall Street Zen
Is Editas Medicine Going to $0?
Editas: Q4 Earnings Snapshot
Editas Medicine (EDIT) Receives a Hold from Wells Fargo
9 Best Gene-Editing Stocks to Buy According to Hedge Funds
Get Editas Medicine News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDIT and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EDIT Media Mentions By Week

EDIT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EDIT
News Sentiment

0.12

0.43

Average
Medical
News Sentiment

EDIT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EDIT Articles
This Week

15

3

EDIT Articles
Average Week

Get the Latest News and Ratings for EDIT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Editas Medicine and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:EDIT) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners